Intermedical Care and Lab Hospital Public Company Limited(TH:IMH)
฿3.16+0.02 (+0.64%)
TH:IMH
Intermedical Care and Lab Hospital Public Company Limited financials statements
฿3.16
At close:+0.02 (+0.64%)
Intermedical Care and Lab Hospital Public Company Limited (IMH) Ratios
Intermedical Care and Lab Hospital Public Company Limited Ratios
TH:IMH's free cash flow for Q2 2026 was ฿18.63M. For the 2026 fiscal year, TH:IMH's free cash flow was decreased by ฿-1.64M and operating cash flow was ฿20.27M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.40 | 0.48 | 1.67 | 6.94 | 4.56 |
| Quick Ratio | 0.36 | 0.45 | 1.60 | 6.76 | 4.45 |
| Cash Ratio | 0.05 | 0.02 | 0.23 | 1.83 | 2.27 |
| Solvency Ratio | -0.09 | -0.02 | 0.05 | 0.79 | 1.37 |
| Operating Cash Flow Ratio | 0.18 | 0.14 | 0.29 | 0.70 | 2.40 |
| Short-Term Operating Cash Flow Coverage | 0.65 | 0.18 | 0.69 | 0.00 | 58.25 |
| Net Current Asset Value | ฿ -1.26B | ฿ -845.51M | ฿ -663.20M | ฿ 315.75M | ฿ 337.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.52 | 0.44 | 0.48 | 0.16 | 0.15 |
| Debt-to-Equity Ratio | 1.99 | 1.22 | 1.18 | 0.21 | 0.21 |
| Debt-to-Capital Ratio | 0.67 | 0.55 | 0.54 | 0.17 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.47 | 0.09 | 0.45 | 0.00 | -0.00 |
| Financial Leverage Ratio | 3.87 | 2.80 | 2.48 | 1.32 | 1.40 |
| Debt Service Coverage Ratio | -0.42 | 0.04 | 0.58 | 20.30 | 31.56 |
| Interest Coverage Ratio | -2.37 | -0.39 | 1.95 | 20.52 | 60.72 |
| Debt to Market Cap | 0.92 | 0.74 | 0.49 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.01 | 4.54 | 4.69 | 0.86 | 0.85 |
| Net Debt to EBITDA | -13.34 | 30.21 | 7.89 | 0.08 | -0.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.47% | 19.83% | 36.24% | 52.36% | 66.53% |
| EBIT Margin | -17.86% | -2.75% | 10.60% | 34.70% | 56.39% |
| EBITDA Margin | -10.46% | 3.86% | 16.92% | 40.29% | 60.26% |
| Operating Profit Margin | -17.86% | -2.75% | 10.60% | 34.70% | 56.39% |
| Pretax Profit Margin | -24.23% | -9.84% | 5.15% | 33.01% | 55.46% |
| Net Profit Margin | -25.00% | -9.66% | 3.21% | 27.06% | 44.84% |
| Continuous Operations Profit Margin | -25.77% | -10.10% | 3.25% | 27.05% | 44.84% |
| Net Income Per EBT | 103.15% | 98.14% | 62.31% | 81.95% | 80.85% |
| EBT Per EBIT | 135.71% | 358.12% | 48.59% | 95.13% | 98.35% |
| Return on Assets (ROA) | -8.98% | -3.54% | 1.06% | 15.82% | 35.82% |
| Return on Equity (ROE) | -34.76% | -9.92% | 2.61% | 20.86% | 50.06% |
| Return on Capital Employed (ROCE) | -8.70% | -1.74% | 4.15% | 21.97% | 51.47% |
| Return on Invested Capital (ROIC) | -7.42% | -1.11% | 2.41% | 17.85% | 41.06% |
| Return on Tangible Assets | -13.32% | -5.25% | 2.10% | 18.62% | 41.75% |
| Earnings Yield | -27.13% | -7.31% | 1.32% | 6.42% | 15.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.60 | 2.04 | 1.52 | 1.59 | 3.01 |
| Payables Turnover | 2.71 | 4.84 | 5.21 | 9.37 | 8.74 |
| Inventory Turnover | 28.45 | 31.57 | 20.43 | 19.88 | 18.90 |
| Fixed Asset Turnover | 0.66 | 0.67 | 1.68 | 1.97 | 2.94 |
| Asset Turnover | 0.36 | 0.37 | 0.33 | 0.58 | 0.80 |
| Working Capital Turnover Ratio | -1.90 | -6.26 | 1.88 | 1.25 | 2.34 |
| Cash Conversion Cycle | -42.53 | 115.36 | 188.42 | 208.30 | 98.63 |
| Days of Sales Outstanding | 79.34 | 179.20 | 240.61 | 228.91 | 121.11 |
| Days of Inventory Outstanding | 12.83 | 11.56 | 17.86 | 18.36 | 19.31 |
| Days of Payables Outstanding | 134.70 | 75.40 | 70.05 | 38.96 | 41.78 |
| Operating Cycle | 92.17 | 190.76 | 258.47 | 247.26 | 140.41 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.45 | 0.57 | 0.44 | 0.27 | 1.65 |
| Free Cash Flow Per Share | 0.35 | 0.40 | 0.30 | 0.17 | 1.53 |
| Dividend Paid and CapEx Coverage Ratio | 4.62 | 3.32 | 1.59 | 0.27 | 14.60 |
| Capital Expenditure Coverage Ratio | 4.62 | 3.32 | 3.19 | 2.56 | 14.60 |
| Operating Cash Flow Coverage Ratio | 0.09 | 0.13 | 0.10 | 0.34 | 2.02 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.16 | 0.14 | 0.09 | 0.38 |
| Free Cash Flow Yield | 11.40% | 8.33% | 3.97% | 1.32% | 12.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.69 | -13.60 | 76.00 | 15.56 | 6.40 |
| Price-to-Sales (P/S) Ratio | 0.92 | 1.32 | 2.43 | 4.21 | 2.87 |
| Price-to-Book (P/B) Ratio | 1.28 | 1.36 | 1.98 | 3.25 | 3.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.77 | 12.01 | 25.18 | 76.03 | 8.21 |
| Price-to-Operating Cash Flow Ratio | 6.88 | 8.38 | 17.28 | 46.29 | 7.65 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 0.03 | -0.87 | -0.26 | -0.00 |
| Enterprise Value Multiple | -22.15 | 64.46 | 22.24 | 10.53 | 4.48 |
| Enterprise Value | 1.75B | 1.92B | 2.52B | 2.72B | 2.55B |
| EV to EBITDA | -22.15 | 64.46 | 22.24 | 10.53 | 4.48 |
| EV to Sales | 2.32 | 2.49 | 3.76 | 4.24 | 2.70 |
| EV to Free Cash Flow | 22.06 | 22.59 | 39.01 | 76.58 | 7.73 |
| EV to Operating Cash Flow | 17.29 | 15.78 | 26.78 | 46.62 | 7.20 |
| Tangible Book Value Per Share | -0.30 | 0.70 | -0.86 | 3.11 | 3.15 |
| Shareholders’ Equity Per Share | 2.39 | 3.51 | 3.84 | 3.88 | 3.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.06 | -0.03 | 0.37 | 0.18 | 0.19 |
| Revenue Per Share | 3.32 | 3.60 | 3.13 | 2.99 | 4.39 |
| Net Income Per Share | -0.83 | -0.35 | 0.10 | 0.81 | 1.97 |
| Tax Burden | 1.03 | 0.98 | 0.62 | 0.82 | 0.81 |
| Interest Burden | 1.36 | 3.58 | 0.49 | 0.95 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.20 | 0.19 | 0.27 | 0.19 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.54 | -1.63 | 2.73 | 0.28 | 0.84 |
Currency in THB
